Bioline Rx Ltd - ADR

XNAS:BLRX

2.86

+0.11 (+4.12%)

7:37:48 PM EDT: $2.82 -0.04 (-1.51%)

Market Cap (Intraday)	12.46M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.34 Million
Adjusted EPS	-$1.04

See more estimates

10-Day MA	$2.59
50-Day MA	$2.53
200-Day MA	$3.26

See more pivots

Bioline Rx Ltd - ADR Stock, XNAS:BLRX

Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in, HaMerkaz 7177871

Israel

Phone: +972.8.642.9100

Number of Employees: 38

http://www.biolinerx.com

Description

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.